No Data
No Data
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator
Express News | Gilead Showcases Livdelzi's Efficacy And Tolerability In PBC, With 60% Response Rate Among Patients With Prior Fibrate Or OCA Use, At EASL 2025
Express News | Gilead's Bulevirtide Shows Durability In Chronic HDV, With 90% of Patients on Long-Term Therapy Maintaining Undetectable HDV RNA Off-Treatment
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Gilead Sciences Down Nearly 5%, On Track for Largest Percent Decrease Since January 2024 -- Data Talk
Unusual Options Activity: SN, GILD and Others Attract Market Bets, SN V/OI Ratio Reaches 253.5
小粉红的papa : It seems that not many people pay attention to biopharmaceutical Stocks, it's quite niche.
Everyone only invests in Technology Stocks.